Patent details

Basic Information

Publication number:

EP2922534

PCT Application Number:

US2013070625

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138575196

PCT Publication Number:

WO2014081675

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES

French Title of Invention:

MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES

German Title of Invention:

VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG NEURODEGENERATIVER ERKRANKUNGEN

SPC Number:

Dates

Filing date:

18/11/2013

Grant date:

08/04/2020

EP Publication Date:

30/09/2015

PCT Publication Date:

30/05/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2020

EP B1 Publication Date:

08/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/11/2020

Expiration date:

18/11/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/04/2020

 

 

Name:

Golden Biotechnology Corporation

Address:

101 Hudson Street Suite 2100, Jersey City NJ 07302, United States (US)

Inventor

1

Name:

WEN, Wu-Che

Address:

Taiwan (TW)

2

Name:

CHEN, Chih-Ming

Address:

Taiwan (TW)

3

Name:

LIU, Sheng-yung

Address:

Taiwan (TW)

Priority

Priority Number:

201261729295 P

Priority Date:

21/11/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/122; A61K 36/07; A61P 25/00; A61P 25/16; A61P 25/28;

Publication

European Patent Bulletin

Issue number:

202015

Publication date:

08/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages